The global Clinical Trials Market is on a growth trajectory, with projections indicating it will reach $102.20 billion by 2031, representing a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. This growth is underpinned by several factors, including a focus on rare diseases, the increasing adoption of personalized medicine, and growing research and development (R&D)...
Transcriptomics and EpigeneticsNext Generation Sequencing technologies are revolutionizing other areas of genomics beyond whole genome and exome sequencing. RNA sequencing, also known as RNA-seq, allows comprehensive analysis of the transcriptome at a depth and scale not possible before Next Generation Sequencing. Scientists are using RNA-seq to explore alternative splicing, gene fusions,...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian